Healthcare workers often have the foresight to know when patients are positive, while knowledge of cases in the community is less likely.
Gaps continue to exist when it comes to understanding how and where potential exposures to SARS-CoV-2/COVID-19 occur in a healthcare setting-exposures to infection preventionists and other healthcare workers, as well as to patients. That’s just one of the findings in a new study by the US Centers for Disease Control and Prevention that sheds light on healthcare worker infections. Are there periods of unprotected exposure? Breaks in personal protective equipment (PPE)? How long was the duration of exposure? These are all critical pieces to understanding exposure risks within healthcare settings.
Published in the CDC’s Morbidity and Mortality Weekly Report(MMWR), investigators reviewed COVID-19 cases in the United States from February 12-April 9.
Of the 315,531 cases reported to the CDC during this time, only 16% had data about whether the case involved a healthcare worker-of those, 9,282 (19%) reported that they were healthcare workers. Overall, the median age of healthcare workers identified in this group was 41, 73% were female, and 38% reported at least 1 underlying health condition.
A majority of healthcare workers reported symptoms, and 55% of those with data on exposure, noted contact with a COVID-19 patient only in a healthcare setting. Ninety percent of healthcare workers with COVID-19 were not hospitalized but there were 27 deaths, which occurred most frequently in those 65 years or older.
The report notes that “among 315,531 U.S. COVID-19 cases reported to CDC during February 12–April 9, data on HCP [healthcare personnel] occupational status were available for 49,370 (16%), among whom 9,282 (19%) were identified as HCP. Data completeness for HCP status varied by reporting jurisdiction; among 12 states that included HCP status on >80% of all reported cases and reported at least one HCP patient, HCP accounted for 11% (1,689 of 15,194) of all reported cases.”
Overall, there was data on only 1,423 cases in regard to exposure to laboratory-confirmed COVID-19 patients. Fifty-five percent reported only healthcare-setting exposure within 14 days prior to their illness onset, but 27% reported only household contact, and 13% cited community setting contact with a confirmed case, and 5% reported contact in more than one setting.
This is particularly interesting as it underscores the lack of community-based testing for many states during the timeframe and that much of the testing is occurring in hospitals. Moreover, healthcare workers often have the foresight to know when patients are positive, while knowledge of cases in the community is less likely.
It’s likely that this is a low representation of the volume of HCWs with COVID-19, as many had mild symptoms, but sheds light on the importance of understanding more of the work-based risk factors. While exposures can occur in the community, it behooves us to understand the potential for healthcare-based risk in order to address and minimize it.
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.